title: Dipyridamole inhibits red cell-induced platelet activation.
abstract: We have recently shown that red blood cells can induce spontaneous platelet aggregation (SPA) in whole blood ex vivo, which could be inhibited by dipyridamole. Since this drug, at therapeutic doses is not an effective inhibitor of platelet aggregation in platelet rich plasma, the inhibition of platelet interaction with the red cell was thought to be the mechanism of its action. Values for the percentage fall in the single platelet count due to SPA in whole blood after 3 and 6 min rollermixing were: control 15 +/- 2.2 and 42 +/- 2.9; 6 microM dipyridamole 6 +/- 1.1 (P less than 0.001) and 31 +/- 2.6 (P less than 0.01); 12 microM dipyridamole 2 +/- 0.9 (P less than 0.0005) and 22 +/- 2.3 (P less than 0.0005) (mean +/- SEM, n = 10). Electron microscopic observation revealed that the aggregation involves an initial platelet adhesion to the red blood cell; the adherent platelets then become activated and serve as foci for the growing aggregates. Dipyridamole appeared to inhibit the initial platelet adhesion to the red cell (the principal trigger mechanism for SPA) which may mimic the initiation of thrombosis in some situations in vivo. The inhibitory effect of dipyridamole on the platelet-red cell interaction suggests that this drug has antithrombotic potential in situations where red blood cells have a trigger role in platelet activation and may explain why the drug has been more effective in some situations than in others.
authors.affiliation: University of Dundee, Department of Medicine, Ninewells Hospital, U.K.
authors.forename: A R
authors.initials: AR
authors.lastname: Saniabadi
authors.forename: R H
authors.initials: RH
authors.lastname: Tomiak
authors.forename: G D
authors.initials: GD
authors.lastname: Lowe
authors.forename: J C
authors.initials: JC
authors.lastname: Barbenel
authors.forename: C D
authors.initials: CD
authors.lastname: Forbes
mesh_terms: D000328:Adult; D002448:Cell Adhesion / Q000187:drug effects*; D004176:Dipyridamole / Q000494:pharmacology*; D004912:Erythrocytes / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors
chemical_list: D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole